Paediatric Vaccines are administered to children to help them stay away from several infectious disease such as, diphtheria, measles ,haemophilus Influenza and poliomyelitis. Apart from providing protection against infectious diseases, these vaccines also aid in the development of children's immune systems. Generally, paediatric vaccines are heat-killed or inactivated viruses that have lost their pathogenicity, or ability to cause disease. Furthermore, these inactivated antigens might trigger the immune system to create antibodies against the virus that has infected the body. As a result, they assist the immune system in future protection against infectious and non-infectious diseases.
The "Global Paediatric Vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the paediatric vaccine market with detailed market segmentation by type, vaccine form, application and end user. The report provides key statistics on the market status of the leading paediatric vaccine market players and offers key trends and opportunities in the market.
- Based on type the market is segmented as, monovalent and multivalent.
- Based on vaccine form the market is segmented as, Attenuated Live Viruses, Inactivated Viruses, Subunits, Toxoids, Recombinant, Polysaccharides and Conjugates.
- Based on application the market is segmented as, infectious disease, allergy.
- Based on end user the market is segmented as, Hospitals, Pediatric Clinics, Academic & Research Organizations and Others.
- Increasing prevalence of chronic and infectious diseases in children.
- Growing awareness about the benefits of vaccination for fighting against the disease.
- Government initiatives for creating awareness for vaccination.
- Extensive R&D activities to develop novel and innovative vaccines to fight paediatric infections and disorders is also expected to fuel the market growth.
- However, high cost associated with development of vaccines, strict regulatory guidelines are expected to restrain market growth during the forecast period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The paediatric vaccine market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the paediatric vaccine market in these regions.
IMPACT OF COVID-19 ON PAEDIATRIC VACCINE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. The pharmaceutical and biopharmaceutical companies have focused their attention on developing effective vaccine against COVID-19 which is affecting the paediatric market a bit. This causing slowing down of production for other vaccines which is affecting the global paediatric vaccine market in large extent. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the paediatric vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from paediatric vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for paediatric vaccine in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the paediatric vaccine market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Pfizer Inc.
- Glaxosmithkline, Plc
- Merck Sharp and Dohme Corp
- Panacea Biotec Ltd
- Sinovac Biotech
- Bio Med Pvt. Ltd.
- CSL Limited
- Serum Institute of India Pvt. Ltd
- Indian Immunologicals Ltd
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.